Physician

Charles F Bou-Abboud, MD

According to 2025 Medicare claims, Charles Bou-Abboud, MD (NPI: 1255324844) practices gastroenterology in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is CHARLES F BOU-ABBOUD MD PLLC (NPI: 1801137104) and primary practice location at 25801-9998. Bou-Abboud is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Bou-Abboud's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 831 traditional Medicare patients, billed 1,949 HCPCS/CPT codes, and received $175,220 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 3,597 prescription claims across 750 beneficiaries totaling $2,114,287 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 2 records totaling $183. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,489,661 and ending at $2,114,287. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,079	2,821	$262,650
2016	1,099	2,997	$272,697
2017	1,044	2,991	$243,063
2018	1,029	2,701	$236,926
2019	1,014	2,611	$227,374
2020	959	2,475	$213,527
2021	991	2,503	$232,570
2022	929	2,369	$206,156
2023	919	2,297	$204,730
2024	831	1,949	$175,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	686	4,021	$1,489,661
2016	716	3,890	$2,267,015
2017	722	4,100	$1,329,005
2018	790	4,122	$1,358,438
2019	792	3,793	$1,306,371
2020	730	3,542	$1,538,958
2021	774	3,678	$1,528,298
2022	798	3,521	$1,497,126
2023	777	3,562	$1,945,548
2024	750	3,597	$2,114,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	90	90	$258
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	150	155	$174
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$118
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	78	86	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	611	1,025	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	70	2,100	$678,349
Stelara	Ustekinumab	13	728	$342,442
Humira Pen	Adalimumab	14	392	$190,728
Xifaxan	Rifaximin	52	1,505	$158,310
Rinvoq	Upadacitinib	17	496	$152,103

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$183	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles F. Bou-Abboud, MD?

Tedicare shows public-source Medicare data for Charles F. Bou-Abboud, MD (NPI 1255324844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles F. Bou-Abboud, MD have ACO affiliation data?

Charles F. Bou-Abboud, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Charles F. Bou-Abboud, MD?

Charles F. Bou-Abboud, MD is linked to CHARLES F BOU-ABBOUD MD PLLC (billing NPI 1801137104) in the available physician profile data.

Does Charles F. Bou-Abboud, MD have Open Payments data?

Charles F. Bou-Abboud, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.